Key Insights

Highlights

Success Rate

92% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

3.0%

1 terminated out of 33 trials

Success Rate

92.3%

+5.8% vs benchmark

Late-Stage Pipeline

27%

9 trials in Phase 3/4

Results Transparency

0%

0 of 12 completed with results

Key Signals

92% success

Data Visualizations

Phase Distribution

24Total
Not Applicable (5)
P 1 (6)
P 2 (4)
P 3 (8)
P 4 (1)

Trial Status

Unknown13
Completed12
Recruiting3
Withdrawn2
Terminated1
Not Yet Recruiting1

Trial Success Rate

92.3%

Benchmark: 86.5%

Based on 12 completed trials

Clinical Trials (33)

Showing 20 of 20 trials
NCT07474870Phase 4Not Yet Recruiting

Outcomes of CTAK Surgery

NCT06859398Not ApplicableCompletedPrimary

KeratoConus Data Acquisition With Topography and Aberrometry

NCT04094090Phase 2Recruiting

Safety and Effectiveness of the PXL-Platinum 330 System for Corneal Cross-Linking in Eyes With Corneal Ectasia

NCT06347900CompletedPrimary

Corneal Topographic Changes in Different Grades of OSA

NCT04667572Phase 1Completed

Safety & Effectiveness of the PXL-Platinum 330 System for CXL Using Riboflavin Solution

NCT04698590Not ApplicableActive Not Recruiting

Wavefront Guided Scleral Lenses for Keratoconus and Irregular Astigmatism

NCT06348368CompletedPrimary

Refractive and Corneal Topographic Characteristics in Upper Egypt Children With High Cylinder

NCT03319082RecruitingPrimary

Observational Registry to Assess the Durability of Effect of CXL in Patients With Corneal Ectasia After Refractive Surgery

NCT05691335Not ApplicableCompletedPrimary

Three Different Cross-linking Protocols for Treatment of Pediatric Keratoconus

NCT04251143RecruitingPrimary

Dresden Corneal Disease and Treatment Study

NCT01152541Phase 3Unknown

Corneal Collagen Crosslinking for Progressive Keratoconus and Ectasia Using Riboflavin/Dextran and Hypotonic Riboflavin

NCT01464268Phase 3Unknown

Transepithelial Corneal Collagen Crosslinking for Keratoconus and Corneal Ectasia

NCT01112072Phase 3Unknown

Corneal Collagen Crosslinking and Intacs for Keratoconus and Ectasia

NCT04905108Phase 3Unknown

Transepithelial (Epi-on) Corneal Collagen Crosslinking to Treat Keratoconus and Corneal Ectasia

NCT04897503Phase 3Unknown

Corneal Collagen Crosslinking for Keratoconus and Ectasia Using Riboflavin/Dextran or Riboflavin/Methylcellulose

NCT05027295Phase 3Unknown

Accelerated Corneal Collagen Crosslinking for Keratoconus and Ectasia Using Pulse or Continuous UV-A Light

NCT04177082Phase 1Completed

Safety and Effectiveness of the PXL-Platinum 330 System for CXL Using Riboflavin Solution

NCT04475900CompletedPrimary

Computer-aided Diagnosis of Ocular Diseases Based on Corneal Biomechanics

NCT05241145Phase 1Completed

Safety and Preliminary Efficacy of IVMED-80 Eye Drops in Keratoconus Patients

NCT04401865Phase 1UnknownPrimary

Safety and Effectiveness of the PXL-Platinum 330 System

Scroll to load more

Research Network

Activity Timeline